Next 10 |
2024-04-16 08:28:48 ET More on pre-market losers & stocks. Financial information for Houston American Energy Financial information for Indonesia Energy Financial information for Organovo Holdings Compare metrics for HUSA to INDO, ONVO Read the f...
2024-04-12 08:32:45 ET More on Pre-market losers & stocks. Candel Therapeutics receives FDA orphan drug designation for its pancreatic cancer treatment Adial stock rallies 81% on data for alcohol abuse drug Seeking Alpha’s Quant Rating on Adial Pharmaceuti...
2024-04-11 08:34:06 ET More on SciSparc Ltd. SciSparc gains on grant of patent for core technology in multiple jurisdictions in Europe SciSparc gains as Clearmind partnership yields 3 new international patent applications Financial information for SciSparc Ltd. ...
TEL AVIV, Israel, April 11, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that it signe...
TEL AVIV, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that as part ...
MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 21, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the develo...
2024-03-18 07:44:53 ET More on premarket gainers & stock. Tilray: Big Opportunities Ahead In Germany And Alcohol Segment Aurora Cannabis: Barely Surviving Or Soon To Be Thriving? Canopy Growth Corporation (CGC) Q3 2024 Earnings Call Transcript Tilray wins...
TEL AVIV, Israel, March 18, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, t...
First patient has been dosed in the randomized, controlled, double blind clinical trial for Autism Spectrum Disorder in pediatric patients TEL AVIV, Israel, March 14, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmace...
MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 12, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the develo...
News, Short Squeeze, Breakout and More Instantly...
SciSparc Ltd. Company Name:
SPRC Stock Symbol:
NASDAQ Market:
Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial res...
Shares of Macatawa Bank Corporation (NASDAQ: MCBC) rose sharply in today’s pre-market trading after Wintrust Financial Corporation (NASDAQ: ...
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial resul...